Included in the formulation
АТХ:D.01.A.E Other antifungal agents for external use
Pharmacodynamics:Has a disinfectant and antiseptic effect against mycobacteria, gram-positive and gram-negative bacteria. It shows fungistatic activity with respect to yeast fungi of the species Candida and optional pathogenic fungi of the species Scopulariopsis. Suppressing growth Trichophyton gypseum and Microsporum canis.
Pharmacokinetics:It is applied locally, does not have systemic action.
Indications:It is used to treat and prevent dermatomycosis: interdigital / plantar foot dermatomycosis, epidermophytosis, trichophytosis. Used for mycotic eczema, candidiasis and mixed skin infections, mycosis of the external auditory canal.
I.B35-B49.B35 Dermatophytosis
I.B35-B49.B35.3 Mycosis of the feet
I.B35-B49.B35.6 Epidermophytosis inguinal
I.B35-B49.B35.8 Other dermatophytosis
I.B35-B49.B37.2 Candidiasis of skin and nails
VIII.H60-H62.H62.2 * External otitis with fungal infections
Contraindications:Individual intolerance.
Carefully:Increased individual sensitivity.
Pregnancy and lactation:Recommendations for FDA - category is not defined. It is used with caution during pregnancy and lactation in cases where the intended benefit exceeds the risk to the fetus and newborn.
Dosing and Administration:With a solution, treat the affected areas: apply pointwise or rub 2-3 times a day. To avoid relapse (after an acute period of the disease) continue to use at a frequency of 1-2 times a week for 4 weeks.
Side effects:Burning, itching, photosensitivity, allergic reactions.
Overdose:With accidental ingestion, nausea, vomiting, diarrhea, hyperhidrosis, agitation with subsequent loss of consciousness develop.
Treatment is symptomatic.
Interaction:Not described.
Special instructions:It is recommended to avoid getting chloronitrophenol in the eyes.
If there is no therapeutic effect, the drug should be discontinued within a week.